Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreo Medical Regulatory News (CREO)

Share Price Information for Creo Medical (CREO)

Share Price is delayed by 15 minutes
Get Live Data
13.50    0.00 (0.00%)
Bid:
13.25
Ask:
13.75
Spread: 0.50 (3.774%)
Market Cap: £65.58m
CREO Live PriceLast checked at - London Stock Exchange

Intraday Creo Medical Share Chart

Directorate Change

29 Jun 2009 07:00

RNS Number : 6190U
China Real Estate Opportunities PLC
29 June 2009
 



CHINA REAL ESTATE OPPORTUNITIES PLC

Board Changes

China Real Estate Opportunities plc ('"CREO" or the "Company"announces the appointment of Richard Anthony David to the Board. Mr David, aged 46, is Managing Director of Treasury Holdings China Limited and based in Shanghai. He has worked in the real estate industry since 1981 and been based in China since 1999. He joined Treasury Holdings China Limited in August 2007 having previously been Head of China Real Estate for Macquarie Bank Limited of Australia.

The Directors would also like to announce that Mr Robert Tincknell, non-executive Director of the Company, has resigned from the Board to take up a Directorship with Real Estate Opportunities plc ("REO"). Mr Tincknell was previously based in Shanghai and held the position of Managing Director in Treasury Holdings China Limited until early 2008 when he returned to the UK to take up the position of Managing Director of Treasury Holdings UK assuming operational responsibility for the UK activities of REO.

As with all appointments to the board of the Company, Mr David's appointment is subject to consent from the Jersey Regulator. Having regard to the residence of the Directors and the location of the Company's business and assets, The Panel on Takeovers and Mergers has confirmed that, upon Mr David's appointment becoming unconditionalit would no longer regard the Company as one to which the City Code on Takeovers and Mergers would apply.

Ray Horney, Chairman of CREO, commented:

"I would like to thank Rob for his contribution to the Company since its launch and welcome the appointment of Richard to the Board." 

Details of Mr David's directorships in the last five years and current directorships are detailed below:

Past directorships held within the last five years

Past directorships held within the last five years

Anting Investments Limited

Austian (Tianjin) Property Development Co Limited

China Property Investments Limited

First China Property Development Limited

First China Property Group Limited

First China Property Management Limited

Macquarie (Tianjin) Property Services Co. Ltd

Macquarie Hallway Property Limited

Macquarie Jin Lin (Mauritius) Pty Ltd

Macquarie Jin Lin Pty Limited

Macquarie Property China Pty Limited

Macquarie Real Estate Asia Limited

Markgold International Housing and Land Consulting (Beijing) Co Ltd

Markgold International Housing and Land Consulting (Shanghai) Co Ltd

Pasley International Limited

San Ling Investments Limited

Shanghai Anting Waratah Real Estate Development Co, Limited

Shanghai Chengli Properties Co Ltd

Shanghai International Company Limited

Shanghai Pdg Waratah Property Co., Ltd

Tianjin Macquarie Property Development Management Co Limited 

Current directorships

Shanghai Huatian Property Development Co., Ltd 

Shanghai Central Land Property Co., Ltd

Shanghai Vision Honest Real Estate Development Co., Ltd

Beijing Dream Land Industrial Development Co., Ltd

Beijing Treasury Industrial Development Co., Ltd

Qingdao Shangshi CREO Real Estate Co., Ltd 

Qingdao CREO Logistics Park Co., Ltd

Nanjing CREO Investment Consulting Co., Ltd

Treasury (Shanghai) Real Estate Consulting Co., Ltd

Treasury Holdings (Shanghai) Property Management Co., Ltd

Treasury Holdings China Limited Qingdao Rep. Office

Treasury Holdings Real Estate (HK) Ltd

Treasury Holdings Limited

Jagard Pty Ltd

There are no further details required to be disclosed in respect of Mr David's appointment pursuant to schedule 2(g) of the AIM rules. 

 

ENDSContact: CREORay Horney, Chairman Tel: + 44 (0)1273 775225 Sarah Moriarty, Investor Relations  Tel: +353 1 6189455 Matrix Corporate CapitalPaul Fincham Tel +44 (0) 203206 7000 DavyDes Carville Tel: +353 1 679 6363 Bankside ConsultantsSimon Rothschild, Oliver Winters Tel: + 44 (0)207 367 8888

Murray ConsultantsEd Micheau Tel: + 3531 498 0300

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABUGDLBBDGGCL
Date   Source Headline
15th Jan 20257:00 amRNSFirst robotic-guided lung ablation cases commence
16th Dec 20247:00 amRNSDirector/PDMR Shareholding
31st Oct 20244:36 pmRNSTotal Voting Rights
24th Oct 20243:27 pmRNSDirector/PDMR Shareholding (Replacement)
24th Oct 20242:33 pmRNSDirector/PDMR Shareholding
21st Oct 202410:06 amRNSDirector/PDMR Share Dealings
18th Oct 202410:26 amRNSResult of General Meeting & TVR
17th Oct 20245:29 pmRNSResult of Retail Offer
4th Oct 20247:00 amRNSExtension of Retail Offer Closing Date
1st Oct 20247:00 amRNSResult of Placing
30th Sep 20243:50 pmRNSRetail Offer for up to £5.0 million
30th Sep 20243:46 pmRNSHalf-year Report
30th Sep 20243:45 pmRNSProposed Placing, Launch of ABB, Retail Offer
18th Sep 202412:00 pmRNSStrategic Partnership & 51% subsidiary cash sale
29th Aug 202411:05 amRNSHolding(s) in Company
1st Aug 20247:00 amRNSAward of Shares under Share Incentive Plan
2nd Jul 20247:00 amRNSCreo and Intuitive amend collaboration agreement
26th Jun 202410:51 amRNSResult of AGM
26th Jun 20247:00 amRNSAGM Statement and Directorate Succession Planning
31st May 20247:00 amRNSPosting of Annual Report and Accounts & AGM notice
15th May 20247:00 amRNSFinal Results
13th May 20247:00 amRNSDirectorate Changes
7th May 20247:00 amRNSCreo Medical receives King’s Award for Enterprise
25th Apr 20247:00 amRNSNotice of Results
24th Apr 20247:00 amRNSNHS Speedboat data demonstrates savings
20th Mar 20244:52 pmRNSHolding(s) in Company
19th Mar 20247:00 amRNSWelsh Labour Leader visits Creo’s facilities
13th Mar 20243:05 pmRNSHolding(s) in Company
11th Mar 20242:00 pmRNSLTIP Awards
6th Mar 20244:35 pmRNSHolding(s) in Company
1st Mar 20247:00 amRNSMicrowave Lung Ablation Update
7th Feb 20249:12 amRNSTrading Update - Replacement
7th Feb 20247:00 amRNSTrading Update
5th Feb 20247:00 amRNSStrategic Collaboration with Khalifa University
31st Jan 20247:00 amRNSSpeedboat® UltraSlim roll-out reaches Asia Pacific
22nd Jan 20247:00 amRNSAward of Shares under Share Incentive Plan
10th Jan 20247:00 amRNSFirst use of Speedboat® UltraSlim in Latin America
15th Dec 20237:00 amRNSFirst use of Speedboat® UltraSlim in the USA
13th Dec 20237:00 amRNSFirst European Speedboat® UltraSlim procedure
7th Nov 20237:00 amRNSCapital Markets Day
1st Nov 20237:00 amRNSSpeedboat® UltraSlim: US FDA Clearance
25th Oct 20237:00 amRNSSB UltraSlim: EU launch accelerated by 18 months
16th Oct 202310:16 amRNSChange of Nominated Adviser and Joint Broker
12th Oct 20237:00 amRNSInvestor Presentation
12th Sep 20237:00 amRNSHalf-year Report
5th Sep 20237:00 amRNSNotice of Results
16th Aug 20237:00 amRNSRoyal Oldham SSD service update
3rd Aug 20237:00 amRNSHalf Year Trading Update
28th Jul 20237:00 amRNSTotal Voting Rights
24th Jul 202310:40 amRNSAward of Shares under Share Incentive Plan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.